Finally, it is likely that various cellular mutations can contribute to PEL, especially in EBV-negative cases, since mutations of tumor suppressor genes RB1, TP53, and PTEN are present in a subset of PEL cell lines (3, 19, 20). This evidence concerns the gene PTEN and primary effusion lymphoma.